Treatment for Metastatic Brain Tumors

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Metastatic Brain Tumors
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is for patients with 1-6 brain metastases who will receive neo-adjuvant stereotactic radiosurgery.

Eligible Conditions
  • Metastatic Brain Tumors

Treatment Effectiveness

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: 5 years

1 year
Radiation toxicity
leptomeningeal disease
local control
2 years
overall survival
progression-free survival
5 years
Survival

Trial Safety

Trial Design

0 Treatment Group

30 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,380 Previous Clinical Trials
473,409 Total Patients Enrolled
David Shultz, MDPrincipal InvestigatorUniversity Health Network, Toronto

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: